CI's Q3 results are likely to be aided by strength in the specialty pharmacy business, partly offset by elevated medical ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

At this event, Cigna and Evernorth volunteers came together to show residents how much they are valued for their service.

Cigna (NYSE:CI) beat Street forecasts with its Q3 2024 financials on Thursday as its Evernorth Health Services unit, which houses its pharmacy benefits manager Express Scripts, exceeded ...

Ann Hynes’s rating is based on Cigna’s strong quarterly performance, particularly in their Evernorth segment, which showcased robust operating income growth. The company reported a 3.8% adjusted EPS ...

The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over ...

Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.